Mild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice
/in Hyperthermia, International Publications /von 2019-02-12 / Br J Radiol 2019 Mar;92(1095):20180759On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2019-02-06 / Front Oncol 2019;9:50Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells
/in Breast Cancer, International Publications, Micronutrients /von 2019-02-01 / 2019 Feb;39(2):751-758The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy
/in Dendritic Cells, International Publications /von 2019-02-01 / Immunotherapy 2019 Feb;11(2):75-79
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution